All In Biotech

Drug Trial Radar · NCT00887978

Efficacy and Safety of Oral UT-15C Tablets to Treat Pulmonary Arterial Hypertension

A 16-Week, International, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Oral UT-15C Sustained Release Tablets in Subjects With Pulmonary Arterial Hypertension

Last checked: Nov 20, 2026Latest source record: Jan 15, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 310 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

310

Actual

Start

Jun 2009

Primary completion

Jul 2011

Study completion Jul 2011

Sponsor

Lead sponsor
United TherapeuticsIndustry
Sponsor type
Industry
First posted
Apr 24, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is an international, multi-center, randomized, double-blind, placebo-controlled study in subjects with PAH who are currently receiving approved therapy for their PAH (i.e., endothelin receptor antagonist and/or phosphodiesterase-5 inhibitor). Study visits will occur at 4 week intervals for 16 weeks with the key measure of efficacy being the 6-minute walk test. Study procedures include routine blood tests, medical history, physical exams, disease evaluation, and exercise tests. Patients who complete all assessments for 16-weeks will also be eligible to enter an open-label, extension phase study (FREEDOM - EXT).

Conditions

  • Pulmonary Hypertension

Interventions

  • UT-15C SRDrug

    treprostinil diolamine sustained release tablets

  • PlaceboDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. 6-minute Walk Distance (6MWD)Time frame: Baseline and 16 weeks

Locations

62 sites in 12 countries. Site status is shown where the registry gives one.

  • University of Alabama-Birmingham

    Birmingham, Alabama

  • Arizona Pulmonary Specialist, LTD

    Phoenix, Arizona

  • University of California, San Francisco-Fresno

    Fresno, California

  • UCSD Medical Center

    La Jolla, California

  • West Los Angeles VA Healthcare Center

    Los Angeles, California

  • UC Davis Medical Center

    Sacramento, California

  • Harbor-UCLA Medical Center

    Torrance, California

  • University of Colorado Health Science Center

    Aurora, Colorado

  • University of Florida-Jacksonville

    Jacksonville, Florida

  • Cleveland Clinic Florida

    Weston, Florida

  • Emory University School of Medicine

    Atlanta, Georgia

  • University of Chicago Hospitals

    Chicago, Illinois

  • University of Iowa Hospitals and Clinics

    Iowa City, Iowa

  • Kansas University Medical Center

    Kansas City, Kansas

  • Kentuckiana Pulmonary Associates

    Louisville, Kentucky

  • Maine Medical Center

    Portland, Maine

  • Tufts Medical Center

    Boston, Massachusetts

  • Pulmonary Critical Care Medicine, Brigham and Women's Hospital

    Boston, Massachusetts

  • Mayo Clinic

    Rochester, Minnesota

  • Washington University Hospital

    St Louis, Missouri

  • University of Nebraska Medical Center

    Omaha, Nebraska

  • Newark Beth Israel Medical Center

    Newark, New Jersey

  • Winthrop University Hospital

    Mineola, New York

  • Columbia University Presbyterian Medical Center

    New York, New York

  • Mary M Parkes Center for Asthma, Allergy and Pulmonary Care

    Rochester, New York

  • Duke University Medical Center

    Durham, North Carolina

  • Lindner Center

    Cincinnati, Ohio

  • University of Cincinnati

    Cincinnati, Ohio

  • University Hospitals Case Medical Center

    Cleveland, Ohio

  • Ohio State University

    Columbus, Ohio

  • The University of Toledo

    Toledo, Ohio

  • Legacy Pulmonary Northwest

    Portland, Oregon

  • OHSU

    Portland, Oregon

  • University of Pennsylvania

    Philadelphia, Pennsylvania

  • Allegheny General Hospital

    Pittsburgh, Pennsylvania

  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania

  • UT Southwestern

    Dallas, Texas

  • The University of Texas Health Science Center at Houston

    Houston, Texas

  • Intermountain Medical Center

    Murray, Utah

  • Inova Transplant Center

    Falls Church, Virginia

Showing 40 of 62 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.